Pancreatic Cancer articles, blogs, webinars, videos, fact sheets, resources, etc.
Ask Dr. Domchek: Recent Treatment Options for BRCA-Related Cancers
In the first in an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.
It’s Complicated: Dating While Navigating a BRCA Mutation, Part 2
This is part two of a summary of a Basser Center panel on the ins and outs of dating with a BRCA mutation.
It’s Complicated: Dating While Navigating a BRCA Mutation, Part 1
This is part one of a summary of a Basser Center panel on the ins and outs of dating with a BRCA mutation.
New PARP Inhibitor Trial for BRCA1/2 and PALB2-Related Pancreatic Cancer
A phase II clinical trial that began in August of 2017, “A Phase 2, Open Label Study of Rucaparib in Patients With Advanced Pancreatic Cancer and a Known Deleterious Germline or Somatic BRCA or PALB2 Mutation,” is enrolling patients at the Hospital of the University of Pennsylvania.